Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
Brief description of study
HVTN 405/HPTN 1901 will describe immune responses in study participants with a history of recovering from SARS- CoV-2 infection. A main aim of HVTN 405/HPTN 1901 is to develop antibody assays that can be reliably used to detect SARS-CoV-2 infection in vaccine and monoclonal antibody studies to prevent COVID-19. This information will be critical in illuminating the path to the development and testing of safe and effective vaccine and antibody interventions to prevent COVID-19.
Detailed description of study
How will study participants contribute to HVTN 405/HPTN 1901?
- Participants will attend one required clinic visit and will have the option to attend additional clinic visits two, four and twelve months after the initial visit.
- Each visit includes a questionnaire, blood draw and optional nasal sampling.
- Individuals who have not fully recovered from their infection (i.e., still have symptoms or had a positive test within the preceding two weeks) will not be enrolled.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
COVID-19
-
Age: Between 18 Years - 100 Years
-
Gender: All
Tested positive for COVID-19 by nasopharyngeal, nasal or oral swab.
Updated on
26 Jul 2021.
Study ID: 843127
